21 – 30 of 49
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
The pharmacodynamic effects of telavancin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the presence of human albumin or serum, and in an in vitro kinetic model.
(
- Contribution to journal › Article
-
Mark
Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile
(
- Contribution to journal › Article
- 2006
-
Mark
Frequent emergence of resistance in Clostridium difficile during treatment of C-difficile-associated diarrhea with Fusidic acid
(
- Contribution to journal › Article
-
Mark
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
(
- Contribution to journal › Article
-
Mark
Behandling av patienter med hud- och mjukdelsinfektioner. Resultat av STRAMAs diagnos- och receptundersokning bland allmanlakare
(
- Contribution to journal › Article
- 2004
-
Mark
A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea.
(
- Contribution to journal › Article
-
Mark
Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis.
(
- Contribution to journal › Article
-
Mark
The use of CRP tests in patients with respiratory tract infections in primary care in Sweden can be questioned
(
- Contribution to journal › Article
-
Mark
Penicillin V bör doseras tre gånger dagligen
(
- Contribution to journal › Article